About this Journal Submit a Manuscript Table of Contents 
ISRN Vascular Medicine
Volume 2012 (2012), Article ID 712047, 11 pages
doi:10.5402/2012/712047
Review Article

Preclinical and Clinical Effects of RAS Inhibition with a Focus on Telmisartan

Thomas Unger

CARIM School for Cardiovascular Diseases, Maastricht University, P.O. Box 616, 6200 MD Maastricht, The Netherlands

Received 20 May 2012; Accepted 10 July 2012

Academic Editors: B. Baudin, C. Kanthou, A. Shaish, and A. Suzuki

Copyright © 2012 Thomas Unger. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Thomas Unger, “Preclinical and Clinical Effects of RAS Inhibition with a Focus on Telmisartan,” ISRN Vascular Medicine, vol. 2012, Article ID 712047, 11 pages, 2012. doi:10.5402/2012/712047